ADVERSE REACTIONS The most common adverse reactions (≥5%) reported by patients treated with BELBUCA ® in the clinical trials were nausea, constipation, headache, vomiting, fatigue, dizziness, somnolence, diarrhea, dry mouth, and upper respiratory tract infection. Please see full Prescribing Information, including Boxed Warning and Medication Guide, for BELBUCA ®.